Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: A phase II study

Breast Cancer Research and Treatment

Volumn 54, Issue 2, 1999, Pages 165-171

  Di Costanzo, Francesco ^a   Sdrobolini, Andrea ^a   Manzione, Luigi ^b   Bilancia, Domenico ^b   Acito, Luigi ^c   Gasperoni, Silvia ^a   Valenti, Lanfranco ^a   Fioriti, Lorella ^a   Angiona, Sabrina ^a   Giustini, Lucio ^c  

^a University Hospital   (Italy)

^b SAN CARLO HOSPITAL   (Italy)

^c General Hospital A Murri   (Italy)

Author keywords

Advanced breast cancer; Mitoxantrone; Paclitaxel

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; DRUG TOXICITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MIDDLE AGED; MITOXANTRONE; NEOPLASM METASTASIS; NEOPLASM STAGING; PACLITAXEL; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033015413     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006183215074     Document Type: Article

References (26)

1. Harris JR, Lippman ME, Veronesi U, Willett W: Medical progress: breast cancer. N Engl J Med 327: 7, 1992
2. Rowinsky EK, Cazenave LA, Donehower RC: Taxol - a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990
3. Rowinsky EK, Donchower RC: The clinical pharmacology of paclitaxel (taxol). Semin Oncol 20: 16-25, 1993
4. Holmes FA, Walters RS, Theriault RL: Phase II trial of taxol, an active drug in the treatment of metastalic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991
5. Gianni L, Capri G, Munzone E, Straneo M: Paclitaxel (taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines. Semin Oncol 21 (Suppl 8): 29-33, 1994
6. Abrams JS, Vena DA, Baltz J, Adams J, Montello M, Christian M, Onetto N, Desmond-Hellmann S, Canetta R, Friedman MA, Arbuk SG: Paclitaxel activity in heavily pre-treated breast cancer: a National Cancer Institute Treatment Referral Center trial. J Clin Oncol 13: 2056-2065, 1995
7. Wilson WH, Berg SL, Bryant G, Witles RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt O'Shaughnessy J, Balis PM, Chabner BA: Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol 12: 1621-1629, 1994
8. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR, Van Echo DA, Von Hoff DD, Leyland-Jones B: Hypersensitivity reactions from taxol. J Clin Oncol 8: 1263-1268, 1990
9. Eisenhauer EA, ten Bokkel Huinink W, Swenerton KD, Gianni L, Myles J, van der Burg MEL, Kerr I, Vermorken JB, Buser K, Colombo N, Bacon M, Santabàrbara P, Onetto B, Winograd B, Canetta R: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high dose versus low dose and long versus short infusion. J Clin Oncol 12: 2654-2666, 1994
10. Nabholtz JM, Gelmon K, Bontenbal M, Spielmman M, Catimel G, Conte P, Klaasen U. Numer M, Bonneterre J, Fumoleau P, Winograd B: Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol 14: 1857-1867, 1996
11. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, Caraceni A, Martini C, Stefancli M, Valagussa P, Bonadonna G: Paclitaxel by 3 h infusion in combination with bolus Dox in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose finding and sequence-finding situdy. J Clin Oncol 13: 2688-2699, 1995
12. Kennedy M, Donehower M, Rowinsky E: Treatment or melastatic breast cancer with combination paclitaxel/cyclophosphamide. Semin Oncol 22 (4 Suppl 8): 23-27, 1995
13. Browne MJ, Kennedy T, Cummings F, Sikov W, Akerley W, Donehower R, Clark JW: Phase II study of sequential taxol and cisplatin for the treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 14: 245, 1995
14. Greco FA, Hainsworth JD: Paclitaxel with mitoxantrone with or without 5-fluorouracil, and high dose leucovorin in the treatment of metastatic breast cancer. Semin Oncol 24 (Suppl 17): S17-61-S17-64, 1997
15. Frassinetti GL, Zoli W, Silvestro L, Serra P, Milundri C, Tienghi A, Gianni L, Gentile A, Salzano E, Amadori D: Paclitaxel plus doxorubicin in breast cancer: an Italian experience. Semin Oncol 24 (Suppl 17): S17-19-S17-25, 1997
16. Dombernowsky P, Boesgaard M, Andersen E, Jensen BV: Daxorubicin plus paclitaxel in advanced breast cancer. Semin Oncol 24 (Suppl 17): S17-15-S17-18, 1997
17. Hainsworth JD: The use of mitoxantrone in the treatment of breast cancer. Semin Oncol 22 (Suppl 1): 17-20, 1995
18. Pavesi L, Preti P, Da Prada G, Pedrazoli P, Poggi G, Robustelli della Cuna G: Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer. Anticancer Res 15: 495-502, 1995
19. Alonso MC, Tabernero JM, Ojeda H, Llanos M, Solà C, Climent MA, Seguì MA, Lopez JJ: A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Breast Cancer Res, Treat 34: 15-24, 1995
20. Green JA, Slater AJ, Campbell IR, Kelly V: Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine. Breast Cancer Res Treat 39: 155-163, 1996
21. Henderson IC, Allegra JC, Woodcock T, Wolff S, Bryan S, Cartwright K, Dukart G, Henry D: Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 560-571, 1989
22. Hryniuk WM, Figuredo A, Goodyear M; Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin Oncol 14 (Suppl 4): 3-11, 1987
23. Clemons M, Leahy M, Valle J, Jayson G, Ranson M, Howell A: Review of recent trials of chemotherapy for advanced breast cancer: the taxanes. Eur J Cancer 33: 2183-2193, 1997
24. Fleming F, Janisch L, Vogelzang NJ, Vokes EE, Ratin MJ; Phase I study of escalating doses of mitoxantrone and paclitaxel with granulocyte-macrophage colony stimulating factor support. Cancer 77: 2308-2312, 1996
25. Rosenthal CJ, Ibrahim A, Rambhia H, Bellina D, Di-Pillo F: Paclitaxel (taxol)-mitoxantrone salvage therapy in metastatic carcinoma of the breast - Phase I/II study. Proc Am Soc Clin Oncol 13: 92, 1994
26. Panagos GE; Treatment of advanced and relapsing breast cancer with combination of paclitaxel and mitoxantrone. Semin Oncol 24 (Suppl 3): S3-17-S3-21, 1997